The efficacy of WGA modified daunorubicin anti-resistant liposomes in treatment of drug-resistant MCF-7 breast cancer

References

• Galimberti V, Ribeiro Fontana SK, Maisonneuve P, et al. Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment. Eur J Surg Onc (EJSO) 2016;42:361–8.
   PubMed Web of Science ®Google Scholar
• Lee da H, Jung Jung Y, Koh D, et al. A synthetic chalcone, 2'-hydroxy-2,3,5'-trimethoxychalcone triggers unfolded protein response-mediated apoptosis in cancer cells. Cancer Lett 2016;372:1–9.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Feng Y, Darshika KN, et al. The effect of multidrug resistance modulator HZ08 on pharmacodynamics and pharmacokinetics of adriamycin in xenograft-nude mice. Eur J Pharm Sci 2015;66:109–17.
   PubMed Web of Science ®Google Scholar
• Akashi T, Nishimura T, Takaki Y, et al. Layer II of placental syncytiotrophoblasts expresses MDR1 and BCRP at the apical membrane in rodents. Reprod Toxicol 2016;65:375–81.
   PubMed Web of Science ®Google Scholar
• Lo YL, Ho CT, Tsai FL. Inhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin. Eur J Pharm Sci 2008;35:52–67.
   PubMed Web of Science ®Google Scholar
• Ho WS, Yap KP, Yeo CC, et al. The complete sequence and comparative analysis of a multidrug-resistance and virulence multireplicon incfii plasmid pEC302/04 from an extraintestinal pathogenic Escherichia coli EC302/04 indicate extensive diversity of IncFII plasmids. Front Microbiol 2015;6:1547.
   PubMed Web of Science ®Google Scholar
• Krishna R, Mayer LD. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 2000;11:265–83.
   PubMed Web of Science ®Google Scholar
• Obreque-Balboa JE, Sun Q, Bernhardt G, et al. Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization. Eur J Med Chem 2016;109:124–33.
   PubMed Web of Science ®Google Scholar
• Ren J, Chung-Davidson YW, Yeh CY, et al. Genome-wide analysis of the ATP-binding cassette (ABC) transporter gene family in sea lamprey and Japanese lamprey. BMC Genom 2015;16:436.
   PubMed Web of Science ®Google Scholar
• Kuo YC, Lin CC. Rescuing apoptotic neurons in Alzheimer's disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated nerve growth factor and curcumin. Int J Nanomed 2015;10:2653–72.
   PubMed Web of Science ®Google Scholar
• Murakami Y, Hasegawa Y, Nagano K, Yoshimura F. Characterization of wheat germ agglutinin lectin-reactive glycosylated OmpA-like proteins derived from Porphyromonas gingivalis. Infect Immun 2014;82:4563–71.
   PubMed Web of Science ®Google Scholar
• Pang Z, Feng L, Hua R, et al. Lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats. Mol Pharm 2010;7:1995–2005.
   PubMed Web of Science ®Google Scholar
• Jia L, Li Z, Shen J, et al. Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance. Int J Pharm 2015;489:318–30.
   PubMed Web of Science ®Google Scholar
• Matyszewska D. Comparison of the interactions of daunorubicin in a free form and attached to single-walled carbon nanotubes with model lipid membranes. Beilstein J Nanotechnol 2016;7:524–32.
   PubMed Web of Science ®Google Scholar
• Li XT, Ju RJ, Li XY, et al. Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cells. Oncotarget 2014;5:6497–511.
   PubMed Web of Science ®Google Scholar
• Li X-t, He M-l, Zhou Z-y, et al. The antitumor activity of PNA modified vinblastine cationic liposomes on Lewis lung tumor cells: in vitro and in vivo evaluation. Int J Pharm 2015;487:223–33.
   PubMed Web of Science ®Google Scholar
• Li XT, Tang W, Jiang Y, et al. Multifunctional targeting vinorelbine plus tetrandrine liposomes for treating brain glioma along with eliminating glioma stem cells. Oncotarget 2016;7:24604–22.
   PubMed Web of Science ®Google Scholar
• Li XT, Zhou ZY, Jiang Y, et al. PEGylated VRB plus quinacrine cationic liposomes for treating non-small cell lung cancer. J Drug Target 2015;23:232–43.
   PubMed Web of Science ®Google Scholar
• Shi J-F, Sun M-G, Li X-Y, et al. A combination of targeted sunitinib liposomes and targeted vinorelbine liposomes for treating invasive breast cancer. J Biomed Nanotechnol 2015;11:1568–82.
   PubMed Web of Science ®Google Scholar
• Ju RJ, Li XT, Shi JF, et al. Liposomes, modified with PTDHIV-1 peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer. Biomaterials 2014;35:7610–21.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang X, An S, et al. Pharmacokinetics of neamine in rats and anti-cervical cancer activity in vitro and in vivo. Cancer Chemother Pharmacol 2015;75:465–74.
   PubMed Web of Science ®Google Scholar
• Qin R, Shen H, Cao Y, et al. Tetrandrine induces mitochondria-mediated apoptosis in human gastric cancer BGC-823 cells. PLoS One 2013;8:e76486.
   Google Scholar
• Bazylinska U, Pietkiewicz J, Saczko J, et al. Nanoemulsion-templated multilayer nanocapsules for cyanine-type photosensitizer delivery to human breast carcinoma cells. Eur J Pharm Sci 2012;47:406–20.
   PubMed Web of Science ®Google Scholar
• Guo L, Zhang H, Wang F, et al. Targeted multidrug-resistance reversal in tumorbased on Peg-Pll-Plga polymer nano drugdelivery system. Int J Nanomed 2015;10:4535–47.
   PubMed Web of Science ®Google Scholar
• Song XL, Liu S, Jiang Y, et al. Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG2000-transferrin in treatment of brain glioma. Eur J Pharm Sci 2016;96:129–40.
   PubMed Web of Science ®Google Scholar
• Ngoune R, Peters A, von Elverfeldt D, et al. Accumulating nanoparticles by EPR: A route of no return. J Control Release 2016;238:58–70.
   PubMed Web of Science ®Google Scholar
• Wang XX, Li YB, Yao HJ, et al. The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells. Biomaterials 2011;32:5673–87.
   PubMed Web of Science ®Google Scholar
• Moreno E, Doughty-Shenton D, Plano D, et al. A dihydroselenoquinazoline inhibits S6 ribosomal protein signalling, induces apoptosis and inhibits autophagy in MCF-7 cells. Eur J Pharm Sci 2014;63:87–95.
   PubMed Web of Science ®Google Scholar
• Ma X, Zhou J, Zhang CX, et al. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes. Biomaterials 2013;34:4452–65.
   PubMed Web of Science ®Google Scholar
• Dabrowska C, Li M, Fan Y. Apoptotic caspases in promoting cancer: implications from their roles in development and tissue homeostasis. Adv Exp Med Biol 2016;930:89–112.
   PubMedGoogle Scholar
• Zhang L, Yao HJ, Yu Y, et al. Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells. Biomaterials 2012;33:565–82.
   PubMed Web of Science ®Google Scholar
• Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007;26:1324–37.
   PubMed Web of Science ®Google Scholar
• Jagani HV, Josyula VR, Palanimuthu VR, et al. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating. Eur J Pharm Sci 2013;48:611–18.
   PubMed Web of Science ®Google Scholar
• Huang K, Zhang J, O'Neill KL, et al. Cleavage by caspase 8 and mitochondrial membrane association activate the BH3-only protein bid during TRAIL-induced apoptosis. J Biol Chem 2016;291:11843–51.
   PubMed Web of Science ®Google Scholar
• Roy A, Murakami M, Ernsting MJ, et al. Carboxymethylcellulose-based and docetaxel-loaded nanoparticles circumvent P-glycoprotein mediated multidrug resistance. Mol Pharm 2014;11:2592–9.
   PubMed Web of Science ®Google Scholar
• Zheng M, Kimura S, Nio-Kobayashi J, Iwanaga T. The selective distribution of LYVE-1-expressing endothelial cells and reticular cells in the reticulo-endothelial system (RES). Biomed Res-Tokyo 2016;37:187–98.
   PubMed Web of Science ®Google Scholar
• Zhong H, Zhao X, Zuo Z, et al. Combating P-glycoprotein-mediated multidrug resistance with 10-O-phenyl dihydroartemisinin ethers in MCF-7 cells. Eur J Med Chem 2016;108:720–9.
   PubMed Web of Science ®Google Scholar